Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Arrowhead Pharmaceuticals, Inc. (ARWR) Receiveable Turnover data is not available for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
$240.74M |
|
$-205.28M |
|
-- |
|
$240.74M |
|
$445.74M |
|
$-205.00M |
|
$-1.49M |
|
$-206.49M |
|
$-206.49M |
|
$-209.28M |
|
$-209.28M |
|
$-209.28M |
|
$-209.28M |
|
$-205.00M |
|
$-194.53M |
|
106.75M |
|
106.75M |
|
$-1.92 |
|
$-1.92 |
|
| Balance Sheet Financials | |
$419.52M |
|
$290.26M |
|
$346.03M |
|
$765.55M |
|
$105.46M |
|
-- |
|
$372.93M |
|
$478.39M |
|
$287.16M |
|
$276.90M |
|
$287.16M |
|
107.31M |
|
| Cash Flow Statement Financials | |
$-153.89M |
|
$-96.16M |
|
$253.05M |
|
$108.00M |
|
$110.89M |
|
$2.89M |
|
$78.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-85.16% |
|
-85.16% |
|
-80.81% |
|
-85.78% |
|
-85.27% |
|
$-330.63M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-72.88% |
|
-75.58% |
|
-27.34% |
|
-72.88% |
|
$2.68 |
|
$-3.10 |
|
$-1.44 |
|